BlueDot is a Toronto-based AI company that tracks, contextualizes and anticipates infectious disease risks. Their products aim to help governments, hospitals and businesses protect employees and customers.
August 7, 2019
However, BlueDot recently told BetaKit that calling its round a Series A was "a misclassification of our seed round," and it now considers the funding seed because of the amount that was invested ($2.5 million USD), as well as that the capital "was intended to help us fund the development of our technology, secure initial traction, and build our team.
Prior to that original Series A, BlueDot had already received $500,000 in, ( what MaRS called), seed funding, which BlueDot now considers pre-seed.